Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

被引:0
|
作者
Alain Mina
Hind Rafei
Maya Khalil
Yasmine Hassoun
Zeina Nasser
Arafat Tfayli
机构
[1] American University of Beirut,Department of Internal Medicine
[2] Internal Medicine Resident-University of Miami Miller School of Medicine-Palm Beach Regional Campus,Department of Internal Medicine
[3] American University of Beirut Medical Center,Faculty of Public Health
[4] Free University of Brussels,undefined
来源
BMC Cancer | / 15卷
关键词
Breast cancer; Echocardiography; Anthracycline;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Exercise training during anthracycline-based chemotherapy for breast cancer.
    Fraser, Steve
    Bigaran, Ashley
    Selig, Steve
    LaGerche, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Evolution of angiogenesis following anthracycline-based neoadjuvant chemotherapy in breast cancer
    Baena-Canada, Jose M.
    Gonzalez, Maria J. Palomo
    Arellano, Esperanza Arriola
    Requena, Maria J. Anon
    Rodriguez, Encarnacion Benitez
    MEDICINA CLINICA, 2008, 130 (19): : 721 - 725
  • [23] Changes in protein expression in breast cancer after anthracycline-based chemotherapy
    Lee, Ho-chang
    Lee, JaeOk
    Park, In Ae
    KOREAN JOURNAL OF PATHOLOGY, 2007, 41 (03) : 165 - 170
  • [24] Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy
    Dranitsaris, G
    Tran, TM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2174 - 2180
  • [25] Concomitant radiotherapy, and anthracycline-based chemotherapy in adjuvant breast cancer treatment
    Ivaldi, G. B.
    Leonardi, M.
    Ferrari, A.
    Morra, A.
    Fossa, B. Jereczek
    Vavassori, A.
    Santoro, L.
    Orecchia, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S180 - S181
  • [26] Sequential addition of an anthracycline-based regimen to docetaxel as neoadjuvant chemotherapy in patients with operable breast cancer
    Amat, Sophie
    Mouret-Reynier, Marie-Ange
    Penault-Llorca, Frederique
    Leheurteur, Marianne
    Delva, Remi
    Coudert, Bruno
    Leduc, Bernard
    Dauplat, Jacques
    Cure, Herve
    Chollet, Philippe
    CLINICAL BREAST CANCER, 2006, 7 (03) : 262 - 269
  • [27] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    Wafaa S. El-Sherbeny
    Nesreen M. Sabry
    Radwa M. Sharbay
    Journal of Echocardiography, 2019, 17 : 76 - 83
  • [28] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Chirivella, Isabel
    Bermejo, Begona
    Insa, Amelia
    Perez-Fidalgo, Alejandro
    Magro, Ana
    Rosello, Susana
    Garcia-Garre, Elisa
    Martin, Paloma
    Bosch, Ana
    Lluch, Ana
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 479 - 484
  • [29] Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy
    Dural, Muhammet
    Demir, Lutfiye
    Babayigit, Erdi
    Junushova, Bermet
    Mert, Kadir Ugur
    Ulus, Taner
    Cavusoglu, Yuksel
    Yildiz, Bulent
    Dincer, Murat
    Gorenek, Bulent
    JOURNAL OF ELECTROCARDIOLOGY, 2019, 54 : 5 - 9
  • [30] Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review
    Simoes, Ricardo
    Silva, Luciana Maria
    Valle Mussi Cruz, Andre Luiz
    Fraga, Vanessa Gomes
    Sabino, Adriano de Paula
    Gomes, Karina Braga
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 989 - 996